{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T19:14:50Z","timestamp":1759778090880,"version":"3.43.0"},"reference-count":18,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Due in part to racial disparities and underrepresentation in clinical studies, optimal therapies for Black patients with multiple myeloma remain undefined. This final analysis of GRIFFIN by race showed that the addition of daratumumab (D) to lenalidomide\/bortezomib\/dexamethasone (RVd) provides clinical benefit among both Black and White transplant\u2010eligible newly diagnosed patients compared with RVd alone. However, Black patients were more likely to discontinue \u22651 drug due to treatment\u2010emergent adverse events. In summary, these findings suggest a benefit of D\u2010RVd front\u2010line therapy among Black and White patients and underscore the importance of equitable treatment access for all patients.<\/jats:p>","DOI":"10.1111\/bjh.19386","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T02:33:57Z","timestamp":1710902037000},"page":"2227-2232","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the <scp>GRIFFIN<\/scp> study"],"prefix":"10.1111","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4165-6869","authenticated-orcid":false,"given":"Ajay K.","family":"Nooka","sequence":"first","affiliation":[{"name":"Winship Cancer Institute, Emory University  Atlanta Georgia USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5687-6429","authenticated-orcid":false,"given":"Jonathan L.","family":"Kaufman","sequence":"additional","affiliation":[{"name":"Winship Cancer Institute, Emory University  Atlanta Georgia USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai  New York New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4550-4726","authenticated-orcid":false,"given":"Andrzej","family":"Jakubowiak","sequence":"additional","affiliation":[{"name":"University of Chicago Medical Center  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Efebera","sequence":"additional","affiliation":[{"name":"OhioHealth  Columbus Ohio USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandi","family":"Reeves","sequence":"additional","affiliation":[{"name":"Department of Medicine University of North Carolina at Chapel Hill  Chapel Hill North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya M.","family":"Wildes","sequence":"additional","affiliation":[{"name":"Division of Oncology and Hematology, Department of Internal Medicine University of Nebraska Medical Center  Omaha Nebraska USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.","family":"Holstein","sequence":"additional","affiliation":[{"name":"Division of Oncology and Hematology, Department of Internal Medicine University of Nebraska Medical Center  Omaha Nebraska USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6531-9595","authenticated-orcid":false,"suffix":"Jr","given":"Larry D.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Myeloma, Waldenstr\u00f6m's and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center  Dallas Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1690-0188","authenticated-orcid":false,"given":"Ashraf","family":"Badros","sequence":"additional","affiliation":[{"name":"Greenebaum Comprehensive Cancer Center, University of Maryland  Baltimore Maryland USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyla","family":"Shune","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Cellular Therapeutics University of Kansas Medical Center  Kansas City Kansas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajai","family":"Chari","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai  New York New York USA"},{"name":"University of California at San Francisco  San Francisco California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiling","family":"Pei","sequence":"additional","affiliation":[{"name":"Janssen Research &amp; Development, LLC  Titusville New Jersey USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annelore","family":"Cortoos","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs, LLC  Horsham Pennsylvania USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharmila","family":"Patel","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs, LLC  Horsham Pennsylvania USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas S.","family":"Lin","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs, LLC  Horsham Pennsylvania USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1661-718X","authenticated-orcid":false,"given":"Peter M.","family":"Voorhees","sequence":"additional","affiliation":[{"name":"Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine  Charlotte North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad Z.","family":"Usmani","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center  New York New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7426-8865","authenticated-orcid":false,"given":"Paul G.","family":"Richardson","sequence":"additional","affiliation":[{"name":"Dana\u2010Farber\/Partners Cancer Care  Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,3,19]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2013.301706"},{"issue":"3","key":"e_1_2_9_3_1","first-page":"235","article-title":"Eligibility criteria and enrollment of a diverse racial and ethnic population in multiple myeloma clinical trials","volume":"142","author":"Kanapuru B","year":"2023","journal-title":"Blood"},{"issue":"2","key":"e_1_2_9_4_1","first-page":"S26","article-title":"Disparities in multiple myeloma among African Americans","volume":"115","author":"Bhutani M","year":"2023","journal-title":"J Natl Med Assoc"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-298760"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2022.08.030"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000406"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2204925"},{"key":"e_1_2_9_9_1","unstructured":"DARZALEX\u00ae (daratumumab) [package insert]. Horsham PA: Janssen Biotech Inc.; 2023."},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005288"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(23)00217-X"},{"key":"e_1_2_9_12_1","unstructured":"United States Census Bureau.QuickFacts United States [Internet]. [cited 2021 Sep 21]. Available from:https:\/\/www.census.gov\/quickfacts\/fact\/table\/US\/PST045219"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09124.x"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00653-1"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/OP.22.00781"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010815"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.11.014"},{"issue":"1","key":"e_1_2_9_18_1","article-title":"Treatment outcomes and prognostic factors with lenalidomide, bortezomib, and dexamethasone (RVd) alone versus RVd plus autologous stem cell transplantation (ASCT) in African American (AA) patients (pts) with newly diagnosed multiple myeloma (NDMM) in the determination phase 3 trial","volume":"142","author":"Zonder JA","year":"2023","journal-title":"Blood"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0141-0"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.19386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T10:09:11Z","timestamp":1754993351000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.19386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10.1111\/bjh.19386"],"URL":"https:\/\/doi.org\/10.1111\/bjh.19386","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"type":"print","value":"0007-1048"},{"type":"electronic","value":"1365-2141"}],"subject":[],"published":{"date-parts":[[2024,3,19]]},"assertion":[{"value":"2023-10-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}